Dr. Kaan Kavakli

Biography

Prof. Kavakli has been appointed at November 2018; to Chairman position of Dept. Pediatrics, Ege University Medical Faculty, Izmir, Turkey. Dr. Kaan Kavakli has held the position of Chairman of the Department of Paediatric Haematology at Ege University Children’s Hospital in Izmir, Turkey for last 10 years until 2014. In 2000, he was also appointed Director of the Ege Haemophilia Centre and Ege Hemophilia Association. He is the general director of Hemophilia Federation (of Turkey) which consists 12 regional hemophilia associations in Turkey since 2005. Dr Kavakli was Chairman of both the Ethics Committee of Ege University Medical Faculty and the Haemostasis and Thrombosis Subcommittee of the Turkish Pediatric Haematology Society for more than 10 years of duration until last year. His academic interests focus on haemostasis and thrombosis (especially hemophilia care), and he has recently published work that identifies a number of mutations in Turkish patients with haemophilia and inhibitors and Radioisotope Synovectomy for hemophilic artropathy. Among other papers, he has also published on the role of circumcision in the social and cultural integration of haemophilic boys and treatment options in inhibitor patients. Dr Kavakli is a member of numerous international societies and a reviewer for the journals; Journal of Thrombosis and Haemostasis, Thrombosis and Haemostasis, Haemophilia, Clinical Applied Thrombosis and Haemostasis, Pediatric Hematology and Oncology, Hematologica, Pediatrics and Pediatric Blood and Cancer. Dr. Kavakli has performed some international phase 1-2-3-4 clinical trials related hemophilia as principal investigator in Turkey. Kaan Kavakli is one of the editorial board members of Haemophilia Journal (2010-2025). He is the first treater of hemophilia gene therapy for Turkey since 2019.

Publications